Hong Kong Securities Investment
A licensed institution's perspective on China's new economy capitalization
Licensed under SFC Type 6 and Type 9, SkyW participates across the full Hong Kong capital markets cycle.
Primary Markets
SkyW acts as cornerstone and anchor investor in Hong Kong IPOs — providing not just capital, but institutional credibility signals that materially improve subscription rates and pricing stability. Recent participation spans: hard tech (Cambricon, UBTECH, Horizon Robotics), new consumption (Chow Sang Sang, Mixue, Guti), and healthcare (Insilico Medicine, Lepu Biopharma).
Secondary Markets
SkyW leverages deep primary market intelligence and Greater Bay Area industrial networks to identify mispriced opportunities in Hong Kong's technology and new economy sectors.
Value for International Investors
Co-participating in HK IPO cornerstone tranches through a licensed institution represents the most compliant and efficient entry point into China's new economy assets for Singapore family offices and Middle Eastern capital.
HONG KONG OFC · EMINENCE
Related Sub-Fund Themes
Eminence Global Master Fund OFC · BUB855
Names, identifiers and dates follow the directory supplied by the company; official names remain in English. Theme links are for navigation only and do not confirm mandates, holdings or subscription availability. Investment scope, risks and eligibility are governed by definitive fund documents. Listing here is not a public offer or regulatory endorsement.
View all ten sub-funds →Learn more or discuss partnership opportunities
Contact Us